Gemzar and Chickenpox - a phase IV clinical study of FDA data
Summary:
Chickenpox is reported as a side effect among people who take Gemzar (gemcitabine hydrochloride), especially for people who are female, 50-59 old, also take Percocet, and have Colon cancer metastatic.
The phase IV clinical study analyzes which people have Chickenpox when taking Gemzar. It is created by eHealthMe based on reports of 20,184 people who have side effects when taking Gemzar from the FDA, and is updated regularly.
What is Gemzar?
Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.
What is Chickenpox?
Chickenpox (infection with varicella zoster virus) is found to be associated with 334 drugs and 590 conditions by eHealthMe. Check the latest studies of Chickenpox.
20,184 people reported to have side effects when taking Gemzar.
Among them, 13 people (0.06%) have Chickenpox.

Among these 13 people:
What is the gender of people who have Chickenpox when taking Gemzar? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Chickenpox when taking Gemzar? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
What are other drugs people take besides Gemzar? *
- Zometa: 13 people, 100.00%
- Dilaudid: 13 people, 100.00%
- Neurontin: 13 people, 100.00%
- Navelbine: 13 people, 100.00%
- Lasix: 13 people, 100.00%
- Lamictal: 13 people, 100.00%
- Faslodex: 13 people, 100.00%
- Droperidol: 13 people, 100.00%
- Compazine: 13 people, 100.00%
- Percocet: 13 people, 100.00%
What are other side effects people have besides Chickenpox? *
- White Blood Cell Count Decreased: 13 people, 100.00%
- Fatigue (feeling of tiredness): 13 people, 100.00%
- Herpes Zoster: 13 people, 100.00%
- Pulmonary Embolism (blockage of the main artery of the lung): 13 people, 100.00%
- Hypoaesthesia (reduced sense of touch or sensation): 13 people, 100.00%
- Pleural Effusion (water on the lungs): 13 people, 100.00%
- Hypokalemia (low potassium): 13 people, 100.00%
- Pain: 13 people, 100.00%
- Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 100.00%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 13 people, 100.00%
What are the existing conditions these people have? *
- Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Gemzar and have Chickenpox?
- Check whether Chickenpox is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Gemzar:
- Gemzar (20,315 reports)
Chickenpox treatments and more:
- Chickenpox (3,552 reports)
How severe was Chickenpox and when was it recovered:
Expand to all the drugs that have ingredients of gemcitabine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gemzar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Chickenpox:
- Chickenpox (334 drugs)
Browse all the conditions that are associated with Chickenpox:
- Chickenpox (590 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemzar) and Gemzar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Warfarin Sodium and Tolbutamide - 8 seconds ago
- Mental Disorder and Heart Rate Decreased - 11 seconds ago
- Could Wellbutrin Sr cause Diverticulitis? - 22 seconds ago
- Tricor and Niacin drug interactions for women aged 40-49 - 27 seconds ago
- Ativan and Relpax drug interactions for women aged 40-49 - 27 seconds ago
- Could Diphen cause Haptoglobin Decreased? - 28 seconds ago
- Neosar and Lovastatin drug interactions for women aged 60+ - 29 seconds ago
- Profen and Septra drug interactions for men aged 20-29 - 30 seconds ago
- Could Hydroxyzine cause Bone Density Abnormal? - 37 seconds ago
- Vesicare and Not Effective for Men aged 30-39 - 49 seconds ago